The Fenway Institute, Fenway Health, Boston, MA

Slides:

Advertisements

Similar presentations

Kuala Lumpur, Malaysia, 30 June - 3 July 2013 How to manage virologic non- responders, non-genotype 1, relapsers IAS 2013, Session: HCV.

Advertisements

Using longitudinal, population-based HIV surveillance to measure the real-world impacts of ART scale-up in KwaZulu- Natal, South Africa Frank Tanser Presentation.

Ensuring Community Participation in Developing An HIV Prevention Intervention for Psychiatric Settings: A US-Brazil Collaboration M.L. Wainberg 1, V. Terto.

THE NATIONAL CENTER for RESPONSIBLE GAMING

EFFICACY OF A RANDOMIZED INTERVENTION TRIAL PROMOTING FEMALE CONDOM USE AMONG FEMALE SOUTH AFRICAN TERTIARY STUDENTS Jenni Smit, Susie Hoffman, Zonke Mabude,

Institute for Health and Society Institute for Health and Society Improving Health and Advancing Health Equity Through Community and Academic Partnerships.

1 A frank dialogue on the future of HIV treatment All the way from the factory to the patient Sunday 20 th July 2014, 13:30 – 15:30 Presented at the 20.

The Overlap of HIV, Key Populations and Psycho-Stimulant drugs CRISTINA PIMENTA, PhD Brazilian Ministry of Health National AIDS Programme Consultant.

Washington D.C., USA, July 2012www.aids2012.org Treatment as Prevention: It is complex: Let us work on it Kenneth H. Mayer Fenway Health Beth Israel.

Use and acceptability of biomedical HIV prevention technologies among MSM and MSW in Vietnam Donn Colby, MD, MPH Harvard Medical School AIDS Initiative.

Sustained Treatment as Prevention: Unprotected sex and increases in virological suppression after HAART initiation among participants in HPTN K.H.

Employee health and wellness metrics, measurements, and evaluation - - the building blocks for ROI David A. Alter, M.D., Ph.D., F.R.C.P.C Senior Scientist,

Jesse L. Clark 1, Jerome T. Galea 1, Hector J. Salvatierra 2, Kelika A. Konda 1, Alex Carballo-Dieguez 3, Thomas J. Coates 1, Carlos F. Caceres 2 1. Department.

Fred Gordin Chief, Infectious Diseases Veterans Affairs Medical Center; Washington DC Professor of Medicine; The George Washington University

Welcome to the 10 th Anniversary Meeting of the St. Louis Diabetes Coalition December 4, 2008.

Anticipated Risk Compensation with Pre-Exposure Prophylaxis Use among North American Men who have Sex with Men Using an Internet Social Network D Krakower,

Myron S. Cohen, MD Protocol Chair 6 th IAS Conference, Rome, Italy July 18, 2011 HPTN 052: Summary.

Threshold, Amory Faulkner, oil on canvas 1 The prospects of elimination of HIV with test and treat strategy Mirjam Kretzschmar 1,2 Maarten Schim van der.

HIV, Race and Risk in Atlanta, GA: Data from Emory University Studies Patrick Sullivan, DVM, PhD Emory University Center for AIDS Research.

( ↑ check it). Careers in ID Medicine ID Fellowships: 2-3 years, following residencies in Internal Medicine or Pediatrics Primary.

 MSM, specifically HIV-positive MSM, have a high risk of anal cancer caused by human papillomavirus (HPV).  It has been suggested that MSM attending.

Decline in incidence of HIV and Hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction? 1. Julius Center, University.

Modeling ‘test and treat’ for HIV in South Africa Jan AC Hontelez 1,2,3, Mark N Lurie 4, Till Bärnighausen 3,5, Roel Bakker 1 Rob Baltussen 2, Frank Tanser.

Drug users in Amsterdam: are they still at risk for HIV? Nienke van der Knaap, Bart Grady, Maarten Schim van der Loeff, Titia Heijman, Arjen Speksnijder,

Lori A. J. Scott-Sheldon, Ph.D. Centers for Behavioral and Preventive Medicine The Miriam Hospital and Department of Psychiatry and Human Behavior Alpert.

2015 Commonwealth Fund International Health Policy Survey of Primary Care Physicians March 1, 2016.

Estimating the population impact of homelessness on HIV viral suppression among people who use drugs Brandon DL Marshall, 1 Beth Elson, 1 Sabina Dobrer,

AIDS in Adolescents and Youngsters Prof. Jorge Peláez Mendoza M.D. Prof. Jorge Peláez Mendoza M.D. Obstetrics and Gynecology Department Obstetrics and.

Hiv testing & counseling in the Netherlands Jan van Bergen, MD, MPh, PhD 12 november 2009.

N ORTHWEST AIDS E DUCATION AND T RAINING C ENTER HIV Prevention in Clinical Care Settings Jeanne Marrazzo, MD, MPH Professor, Division of Allergy and Infectious.

Evidence of international transmission of HCV in pan-European study of HIV- positive men who have sex with men (MSM). M Danta 1,9 *, T van de Laar 4 *,

PrEP should be made available to all HIV-negative individuals on demand Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health Attending.

Expanded PrEP implementation across Australia Expanded implementation of PrEP across Australia 1.

#AIDS2016 Youth Sexual and Reproductive Health in China Results from a National Survey of 18,000 Chinese College Students Chunyan Li.

Characterizing the HIV Epidemic in the Middle East The MENA HIV/AIDS Epidemiology and Response Synthesis Project is financed as a joint activity by the.

Funding Opportunities at the NIH-funded Centers for AIDS Research

BHIVA Satellite Symposium

IAS Satellite Session 25th July 2017 Daniel Were, PhD

Access and response to ART among migrants

Department of Epidemiology

The Incidence of AIDS-related Diseases and HIV-Infection Control in the Republic of Komi V.M. Chzhao State Establishment “The Republican Centre for.

A national stakeholder roundtable

56 Dean Street, Chelsea and Westminster Hospital, London

2016 Commonwealth Fund International Health Policy Survey of Adults in Eleven Countries May 18th, 2017.

ENDING HIV TRANSMISSION ALONG PEOPLE WHO INJECT DRUGS – THE TALE OF TWO CITIES, NEW YORK CITY (USA) AND HAI PHONG (VIETNAM) Risk Factors Study Team: Don.

Illustrating HIV/AIDS in the United States

STI 2018 Understanding and Addressing the HIV and STI Syndemics

Illustrating HIV/AIDS in the United States

One pill a day, can keep HIV away

Illustrating HIV/AIDS in the United States

John de Wit1,2, Dean Murphy2,3, Luxi Lal4,5,6, Jennifer Audsley5,7, Christopher K. Fairley8,9, Mark Stoove4,10, Norm Roth11, Richard Moore12, Ban K.

Illustrating HIV/AIDS in the United States

Illustrating HIV/AIDS in the United States

Syndemics Predict Bio-Behavioral HIV Sexual Transmission Risk Behavior Longitudinally in US HIV Clinics Satyanand Satyanarayana, Steven A. Safren, Brooke.

Migrants Dr Julia del Amo National Center for Epidemiology

The Politics of PrEP The French Experience

Illustrating HIV/AIDS in the United States

Global Optimization of the Response to HIV

Drivers, Barriers And Consequences of HIV Disclosure to HIV-infected Children Age 9-14 Years: A Qualitative Study Among Children and their Caregivers in.

PrEParedness for the Rollout of Effective HIV Prevention among Key Affected Populations in Brazil, Peru, and Mexico The Imprep pROJECT Valdiléa G. Veloso,

TITLE Authors We appreciate the support of the:

STIs among people who use drugs

Leaving no-one behind UNAIDS.

21-22 July 2018 Henry de Vries & Kenneth Mayer

Male CircuMcision as HIV Prevention Global and domestic responses

STI outpatient clinic, Municipal Health Service (GGD) Amsterdam

Paul Stoffels, MD Vice Chairman, Chief Scientific Officer, Johnson & Johnson.

Illustrating HIV/AIDS in the United States

HIV infections newly diagnosed in injecting drug users and men who have sex with men, by country, and year of report, 2002– Injecting drug users.

On behalf of the H-TEAM initiative

Presentation transcript:

The Fenway Institute, Fenway Health, Boston, MA Welcome to STI 2018 Kenneth H. Mayer, M.D. The Fenway Institute, Fenway Health, Boston, MA Department of Medicine, Beth Israel Deaconess Medical Center/Harvard Medical School

Disclosures Unrestricted research grants Gilead ViiV Relations that could be relevant for the meeting Company names Unrestricted research grants Gilead ViiV NIH (NIAID, NIMH, NICHD) Scientific Advisory boards Merck

HIV and STI Synergy Inflammation and/or ulceration BIOLOGY PrEP and TasP ↑HIV transmission and/or acquisition BEHAVIOR STI Condomless sex Multiple partners EPIDEMIOLOGY Higher risk partners, ↑ risk of HIV-infected partner

HIV and STI Synergy Inflammation and/or ulceration BIOLOGY PrEP and TasP ↑HIV transmission and/or acquisition BEHAVIOR STI Condomless sex Multiple partners EPIDEMIOLOGY Higher risk partners, ↑ risk of HIV-infected partner

Major Sessions Setting the stage: epidemiology Key and marginalized populations: factors driving STI epidemics Transmission dynamics Clinical approaches to STI management Emerging STI Diagnostics Best practices and the future of sexual health Emerging issues regarding the global HIV and STI response

Ground Rules Full schedule, need to stay on time Many stakeholders, important to listen to all voices Ample time for informal conversation, during coffee breaks, lunch, poster sessions, reception We hope to publish a scholarly special issue highlighting key data from the meeting

STI2018 Organizing Committee Birgit van Benthem, National Institute for Public Health and the Environment (RIVM), The Netherlands Jan van Bergen, Soa Aids Nederland, Amsterdam | Academic Medical Center, University of Amsterdam | National Institute for Public Health and the Environment (RIVM), The Netherlands Silke David, National Institute for Public Health and the Environment (RIVM), The Netherlands Udi Davidovich, Public Health Service of Amsterdam (GGD), The Netherlands Arjan Hogewoning, Public Health Service of Amsterdam (GGD), The Netherlands Elske Hoornenborg, Public Health Service of Amsterdam (GGD) The Netherlands Marina Klein, McGill University and CIHR Canadian HIV Trials Network, Canada Kenneth Ngure, Jomo Kenyatta University of Agriculture and Technology, Kenya | Department of Global Health, University of Washington, United States Nneka Nwokolo, Chelsea and Westminster Hospital, United Kingdom Maria Oud, Public Health Service of Amsterdam (GGD), The Netherlands Sébastien Morin, International AIDS Society, Switzerland Maria Prins, Public Health Service of Amsterdam (GGD) | Academic Medical Center, University of Amsterdam, The Netherlands Jürgen Rockstroh, University of Bonn, Germany Mauro Schechter, Universidade Federal do Rio de Janeiro, Brazil Maarten Schim van der Loeff, Public Health Service of Amsterdam (GGD) | Academic Medical Center, University of Amsterdam, The Netherlands Darrell Tan, Li Ka Shing Knowledge Institute, Canada Clarissa Vergunst, Public Health Service of Amsterdam (GGD), The Netherlands

Thanks to STI 2018 partners